Can I File a Zantac Cancer Lawsuit?
If you have been watching or reading the news, you might have heard about the Zantac cancer lawsuits. Although no formal recall has been announced by the FDA, representatives from the administration have recommended that people with a prescription talk with their doctor and OTC users should consider an alternative medication or make lifestyle changes to reduce the symptoms of gastrointestinal discomfort.
Zantac cancer lawsuits have been filed because a probable human carcinogen, N-Nitrosodimethylamine (NDMA), has been discovered in Zantac, the generic form of ranitidine. At this time, it is not known how NDMA contaminated the medication nor for how long. Zantac cancer lawsuit lawyers are currently investigating the situation and possible cases.
What is Zantac?
Zantac, also known as generic ranitidine is a popular medication that controls acidity in the stomach. It is used for heartburn, peptic ulcers, gastroesophageal disease, and Zollinger-Ellison syndrome. It may also be used for other conditions, including for the treatment of hives.
Zantac is most commonly taken in capsule form; however, people who are using it as a prescription or on a regular basis may have it injected into the muscle tissue or a vein. Zantac prevents the action of antacids, also known as histamine blockers, from being released into the body. Ranitidine is considered to be a popular drug in the U.S. and currently holds the 50th place for most commonly prescribed drug in the United States. Approximantly 15 million people have a prescription; this number does not include OTC users.
What is N-nitrosodimethylamine (NDMA)?
At this time, the concern with the Zantac medication is the discovery of N-nitrosodimethylamine (NDMA). As a Zantac cancer lawsuit lawyer might explain to you, NDMA is an industrial waste product and probable carcinogen. It has a faint, but distinctive odor, and is yellow in color. NDMA can be found in tobacco smoke and cured meats. It has also been used in industrial lubricants, rocket fuel, and jet fuel.
In 2018, this probable carcinogen was found in several different blood pressure medications, including Valsartan. The contamination was traced to a Chinese based factory. It is thought that a change in the initial manufacturing process resulted in a chemical reaction that produced NDMA. At this time, it is not understood how NDMA contaminated Zantac.
Zantac Cancer Lawsuits
Various lawyers, are investigating the possible link between certain types of cancers and Zantac. NDMA, the contaminant found in the popular medication, has been linked to an increased risk of stomach cancer, bladder cancer, liver cancer, colorectal cancer, prostate cancer, pancreatic cancer, and other health problems. It may be possible to file a lawsuit against the drug manufacturers for a failure to warn about the risk of potential carcinogens being present.